Today: 20 May 2026
Microchip Technology stock price: MCHP heads into Monday after earnings outlook and mixed analyst calls
8 February 2026
1 min read

Microchip Technology stock price: MCHP heads into Monday after earnings outlook and mixed analyst calls

New York, February 7, 2026, 20:23 (EST) — The market is now closed.

Microchip Technology Inc dropped 2.6% on Friday, finishing the session at $76.01. Investors took in the company’s updated guidance along with new analyst commentary. With U.S. markets closed for the weekend, the next move arrives when Nasdaq reopens on Monday.

Microchip’s microcontrollers and embedded chips wind up in everything from vehicles to industrial machinery to consumer gadgets. The company’s order trends serve as a read-through for the pace of the broader “old economy” chip downturn—whether it’s actually letting up, or simply catching its breath.

Another concern? Supply, rather than demand. Reuters said a worldwide memory shortfall is rattling electronics manufacturers, prompting some to trim orders—a development that sent Microchip sliding over 5% after the bell on Thursday.

Microchip reported a 15.6% jump in fiscal Q3 net sales to $1.186 billion, with non-GAAP earnings at 44 cents a share—excluding restructuring and acquisition costs. The company projected March quarter net sales between $1.24 billion and $1.28 billion and non-GAAP EPS in a 48 to 52 cent range. CEO Steve Sanghi flagged a “substantially better” starting backlog for the March quarter, and noted bookings were “strong.” Microchip Technology Incorporated

Microchip Technology declared a quarterly cash dividend of 45.5 cents per share, with payment set for March 10 to holders of record as of Feb. 23. CFO Eric Bjornholt noted net debt dropped by $26 million for the quarter, adding that capital spending remains disciplined.

TD Cowen’s Joshua Buchalter dropped his price target to $70 from $75 and stuck with a Hold rating, saying the outlook probably “failed to meet the bar” following some earlier optimism. He noted a book-to-bill ratio above 1—orders outpacing sales—but called out the shaky visibility on how fast recovery might actually unfold. TipRanks

JPMorgan bumped its price target up to $95 from $85, sticking with an Overweight call after margins and earnings landed above forecasts. With targets moving in both directions, traders could see the stock reacting just as much to tweaks in estimates as to shifts in the topline revenue guide.

BlackRock reported in an SEC filing Friday that it held roughly 54.3 million shares of Microchip as of Jan. 31—good for a 10% stake. No indication of a control shift here, but the filing highlights just how much of the stock sits with institutions.

Bulls face a headache if the supply squeeze lingers or even expands, stretching out delivery wait times and making customers hesitate. Microchip, for its part, is juggling debt reduction alongside capacity expansion—missing the mark there could pressure margins.

With the market closed, attention turns to the details—management’s commentary on backlog, inventory levels, and supply snags, plus any fresh analyst moves on targets. The real gauge comes Monday, when Microchip reopens and traders see if the chip sector’s Friday slide did the trick.

Stock Market Today

  • Trump's Truth Social Withdraws Bitcoin and Bitcoin-Ethereum ETF Applications Amid Market Pressure
    May 20, 2026, 7:22 AM EDT. Trump Media & Technology Group has withdrawn its applications for Bitcoin and Bitcoin-Ethereum exchange-traded funds (ETFs), citing a strategic shift to pursue a different regulatory framework under the Investment Company Act of 1940 ('40 Act) instead of the Securities Act of 1933 ('33 Act). Yorkville America, the investment advisor, highlighted that the '40 Act allows more flexible investment strategies. This move comes amid intense fee competition in the U.S. spot Bitcoin ETF market, valued at $57.4 billion since January 2024, following Morgan Stanley's MSBT launch, which offers a low 0.14% expense ratio. The withdrawal underscores heightened competition and evolving regulatory approaches in the crypto ETF space.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Zhongji Innolight stock slides nearly 4% into China’s Monday open — what traders watch next
Previous Story

Zhongji Innolight stock slides nearly 4% into China’s Monday open — what traders watch next

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026
Next Story

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026

Go toTop